What is Wedbush’s Forecast for SWTX Q2 Earnings?
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) – Wedbush increased their Q2 2025 earnings per share estimates for SpringWorks Therapeutics in a research report issued on Wednesday, February 12th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ($0.68) for the quarter, up from their prior estimate of ($0.71). […]
